 | Atara Biotherapeutics (NASDAQ:ATRA) Now Covered by Mizuho
marketbeat.com - October 13 at 12:32 PM |
 | Atara Biotherapeutics (NASDAQ:ATRA) Stock Price Down 10.6%
americanbankingnews.com - October 13 at 1:46 PM |
| Atara Biotherapeutics (NASDAQ:ATRA) Now Covered by Analysts at Mizuho
americanbankingnews.com - October 13 at 12:26 PM |
 | Atara Biotherapeutics Presents New Magnetization Transfer Ratio Imaging Data and Two-Year Clinical Data from the Open Label Extension of ATA188 for Progressive Multiple Sclerosis at ECTRIMS 2021
finance.yahoo.com - October 13 at 8:06 AM |
| Zacks: Analysts Expect Atara Biotherapeutics, Inc. (NASDAQ:ATRA) to Post -$0.92 Earnings Per Share
americanbankingnews.com - October 9 at 7:06 PM |
| HC Wainwright Reaffirms "Buy" Rating for Atara Biotherapeutics (NASDAQ:ATRA)
americanbankingnews.com - October 5 at 12:48 PM |
| Atara Biotherapeutics (NASDAQ:ATRA) PT Lowered to $27.00
americanbankingnews.com - October 4 at 5:14 PM |
 | Atara Biotherapeutics and Pierre Fabre Enter Strategic Collaboration to Commercialize Tabelecleucel (Tab-cel ®)
businesswire.com - October 4 at 8:44 AM |
| Atara Biotherapeutics and Pierre Fabre Enter Strategic Collaboration to Commercialize Tabelecleucel (Tab-cel®)
finance.yahoo.com - October 4 at 8:44 AM |
| Atara Biotherapeutics (NASDAQ:ATRA) Shares Gap Up to $17.90
americanbankingnews.com - October 1 at 10:50 AM |
| We're Not Very Worried About Atara Biotherapeutics' (NASDAQ:ATRA) Cash Burn Rate
finance.yahoo.com - October 1 at 7:41 AM |
|
| Mizuho Initiates Coverage on Atara Biotherapeutics (NASDAQ:ATRA)
americanbankingnews.com - September 29 at 1:00 PM |
| Atara Biotherapeutics to Present Phase 1 Study Update of ATA188 in Progressive Multiple Sclerosis at ECTRIMS 2021
finance.yahoo.com - September 29 at 5:04 AM |
| Atara Biotherapeutics (NASDAQ:ATRA) Shares Up 2.9%
americanbankingnews.com - September 28 at 1:34 PM |
 | Atara: EMA Grants Accelerated Assessment To Tab-cel - Quick Facts
markets.businessinsider.com - September 27 at 9:34 AM |
| European Medicines Agency Grants Atara Biotherapeutics Accelerated Assessment of tab-cel® for the Treatment of Epstein-Barr Virus Positive Post-Transplant Lymphoproliferative Disease (PTLD)
finance.yahoo.com - September 27 at 9:34 AM |
| Atara Biotherapeutics to Participate in a Panel Discussion at the Citi 16th Annual BioPharma Virtual Conference
finance.yahoo.com - September 2 at 10:11 AM |
| Atara Biotherapeutics, inc (ATRA) Q2 2021 Earnings Call Transcript
finance.yahoo.com - August 17 at 2:37 AM |
 | Atara Biotherapeutics, Inc. 2021 Q2 - Results - Earnings Call Presentation
seekingalpha.com - August 10 at 7:08 AM |
| Atara Biotherapeutics (ATRA) Reports Q2 Loss, Misses Revenue Estimates
finance.yahoo.com - August 9 at 7:48 PM |
| Atara Biotherapeutics Appoints Cell Therapy and Oncology Commercialization Veteran Ameet Mallik to the Board of Directors
finance.yahoo.com - August 9 at 6:06 PM |
| Atara Biotherapeutics Announces Second Quarter 2021 Financial Results and Operational Progress
finance.yahoo.com - August 9 at 6:06 PM |
| Atara Biotherapeutics to Announce Second Quarter 2021 Financial Results on Monday, August 9, 2021
finance.yahoo.com - August 2 at 9:04 AM |
 | Atara Biotherapeutics, Inc. Common Stock (ATRA)
nasdaq.com - July 28 at 11:41 PM |
| Is Atara Biotherapeutics Inc (ATRA) A Good Stock To Buy?
finance.yahoo.com - July 21 at 12:39 PM |
| Atara Biotherapeutics Joins the Rare Disease Company Coalition Alongside Industry Gamechangers
finance.yahoo.com - July 1 at 8:08 PM |
| SVP & Chief Commercial Officer Kristin Yarema Just Bought 165% More Shares In Atara Biotherapeutics, Inc. (NASDAQ:ATRA)
nasdaq.com - June 18 at 8:32 AM |
| Kristin Yarema Is The SVP & Chief Commercial Officer of Atara Biotherapeutics, Inc. (NASDAQ:ATRA) And They Just Picked Up 165% More Shares
finance.yahoo.com - June 18 at 8:32 AM |
| Wednesday 6/16 Insider Buying Report: CORT, ATRA
nasdaq.com - June 16 at 1:48 PM |
| Atara Biotherapeutics Presents Positive Tab-cel® Long-Term Overall Survival Data for Epstein-Barr Virus-Driven Post-Transplant Lymphoproliferative Disease After Solid Organ Transplant at ATC 2021 Virtual Connect
finance.yahoo.com - June 7 at 2:19 PM |
| If You Had Bought Atara Biotherapeutics' (NASDAQ:ATRA) Shares Three Years Ago You Would Be Down 71%
nasdaq.com - June 6 at 1:45 PM |
| Would Shareholders Who Purchased Atara Biotherapeutics' (NASDAQ:ATRA) Stock Three Years Be Happy With The Share price Today?
finance.yahoo.com - May 20 at 9:29 AM |
| J.P. Morgan: These 2 Stocks Could Yield Big Returns in the Coming Year
finance.yahoo.com - May 19 at 5:56 PM |
| Atara Biotherapeutics to Participate at the Cowen Virtual Oncology Innovation Summit
finance.yahoo.com - May 14 at 2:01 AM |
|
| Atara Biotherapeutics Names Cell Therapy & Oncology Leader Cokey Nguyen, Ph.D. as Chief Scientific Officer
finance.yahoo.com - May 10 at 9:31 AM |
 | Atara Biotherapeutics Inc (ATRA) Q1 2021 Earnings Call Transcript
msn.com - May 5 at 8:24 AM |
| Atara Biotherapeutics (ATRA) Reports Q1 Loss, Lags Revenue Estimates
finance.yahoo.com - May 4 at 9:08 PM |
| Atara Biotherapeutics Announces First Quarter 2021 Financial Results and Operational Progress
finance.yahoo.com - May 4 at 4:08 PM |
| Atara Biotherapeutics to Announce First Quarter 2021 Financial Results on Tuesday, May 4, 2021
finance.yahoo.com - April 27 at 6:38 PM |
| Is ATRA Stock A Buy or Sell?
finance.yahoo.com - April 26 at 1:43 AM |
| Here's Why We're Not Too Worried About Atara Biotherapeutics' (NASDAQ:ATRA) Cash Burn Situation
nasdaq.com - April 7 at 5:51 PM |
| Atara Biotherapeutics Becomes Oversold (ATRA)
nasdaq.com - March 26 at 12:52 PM |
| We're Hopeful That Atara Biotherapeutics (NASDAQ:ATRA) Will Use Its Cash Wisely
finance.yahoo.com - March 21 at 12:42 PM |
| Atara Biotherapeutics Presents New Long-Term Overall Survival Data from a Combined Analysis of Phase 2 Tab-cel ® Studies for Epstein-Barr Virus-Driven Post-Transplant ...
businesswire.com - March 14 at 5:11 PM |
| Atara Biotherapeutics Presents New Long-Term Overall Survival Data from a Combined Analysis of Phase 2 Tab-cel® Studies for Epstein-Barr Virus-Driven Post-Transplant Lymphoproliferative Disease at The EBMT 2021 Annual Meeting
finance.yahoo.com - March 14 at 5:11 PM |
| Atara Biotherapeutics to Participate in Virtual 33rd Annual ROTH Conference
finance.yahoo.com - March 9 at 6:06 PM |
| Atara Biotherapeutics Breaks Below 200-Day Moving Average - Notable for ATRA
nasdaq.com - March 5 at 8:03 AM |
| Atara Biotherapeutics Inc (ATRA) Q4 2020 Earnings Call Transcript
finance.yahoo.com - March 2 at 9:43 AM |
| Atara Biotherapeutics, Inc. 2020 Q4 - Results - Earnings Call Presentation
seekingalpha.com - March 1 at 7:09 PM |
| Atara Biotherapeutics Announces Fourth Quarter and Full Year 2020 Financial Results and Operational Progress
finance.yahoo.com - March 1 at 6:24 PM |
| Atara Biotherapeutics to Announce Fourth Quarter and Full Year 2020 Financial Results on Monday, March 1, 2021
finance.yahoo.com - February 18 at 4:29 PM |
